Advertisement
Advertisement
U.S. markets open in 6 hours 12 minutes
Advertisement
Advertisement
Advertisement
Advertisement

China Pharma Holdings, Inc. (CPHI)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.3775+0.0125 (+3.42%)
At close: 03:59PM EST
Advertisement
Sign in to post a message.
  • F
    FactSpeculate
    I wonder if they will put out a press release or just mention it in the next financial filing...that Candesartan is included in the current product portfolio. They seem to believe it will help with the companies income.
    Bullish
  • F
    FactSpeculate
    It would be a blessing if we helped out another time during this critical timing of events!!! No guarantee

    https://news.yahoo.com/beijing-district-orders-mass-virus-131808365.html?fr=sychp_catchall
    Bullish
  • F
    FactSpeculate
    good to know!!! Candesartan is included in our current product portfolios.
    Bullish
  • F
    FactSpeculate
    Is this new on the website or have they been making Candesartan? Says its one of their products...
    http://www.chinapharmaholdings.com/CNSCerebralCardioVasc/102.html
  • F
    FactSpeculate
    Waiting for a response from Diana...will let you all know what it means to see Candesartan on the products list!!!
    Bullish
  • F
    FactSpeculate
    So just like in 2020 they were part of helping out providing testing there’s always that possibility again. Although not likely the fact that people are recommending double masking and China is trying to do the impossible and not have any spread at all don’t you think the hand sanitizer and the mask sales are going to Be through the roof And if they get CANDESARTAN drug we have a real winner
    Bullish
  • F
    FactSpeculate
    Wild Move This morning... Anyone know why it subsided or are we expecting a Candesartan update?
  • F
    FactSpeculate
    Hopefully the company is involved in the extreme Covid-19 testing campaign in China.
    Bullish
  • F
    FactSpeculate
    It would be awesome news if they did another trade of Covid 19 testers... It really helped numbers in 2020... we can only guess they may be widely needed because of the major lockdowns.
  • F
    FactSpeculate
    Who thinks lots of masks are needed to try and have 0 Covid? Who thinks we may help test again and who Hopes CANDESARTAN is a done deal?👋
    Bullish
  • F
    FactSpeculate
    Seems Like Masks stay important but I'm really hoping we get Candesartan Deal
  • F
    FactSpeculate
    Would it make sense because of major lock down Masks and hand sanitizer might have great sales and CANDESARTAN would be A Lovely Icing on the Cake?
  • F
    FactSpeculate
    We need NMPA update... August was 4 months away!!!
  • F
    FactSpeculate
    60 Days are Up and now I want the CANDESARTAN UPDATE!!!
    Bullish
  • L
    Louis
    An interesting insight into Q1 for $CHPI

    It shouldn’t come as a surprise that they have not excelled during COVID-19, though we can argue it shouldn’t have been hit so hard in losses being in the pharma industry. The CEO states this is partially due to the Chinese New Year slowing down production also.

    Whilst it’s not showing the boom I was hoping for, we may still see a bump from some much needed press release. If we can see this jump up beyond .50 breaking line, we will have made sufficient progress, imho.

    Source: https://finance.yahoo.com/amphtml/news/china-pharma-holdings-inc-reports-103000126.html
  • E
    Edward
    China Pharma Holdings (CPHI) Stock: Here’s Why It’s Flying!
    The company has several drugs on the Chinese market that are designed to treat the same types of symptoms that patients dealing with the coronavirus are experiencing. As such, the company’s already approved treatments may lead to the company being able to treat the condition.

    Moreover, CPHI currently owns the only bio manufacturing facility near the epicenter of the outbreak in China. So, not only does the company have drugs that may treat coronavirus, it has the facility and ability to make the treatments and get them to the targeted patient population very quickly.

    As investors start to realize the strategic advantage that the company has when it comes to the treatment of the coronavirus, we’re starting to see strong upward movement.

    https://alphastocknews.com/china-pharma-holdings-cphi-stock-heres-why-its-flying/2547/
    China Pharma Holdings, Inc. (NYSEAMERICAN: CPHI) is rocketing this morning, trading on gains of more than 50% early on. If you go digging for news, you’re not going to find any, but there is a good reason for the run. It seems as though the coronavir
    China Pharma Holdings, Inc. (NYSEAMERICAN: CPHI) is rocketing this morning, trading on gains of more than 50% early on. If you go digging for news, you’re not going to find any, but there is a good reason for the run. It seems as though the coronavir
    alphastocknews.com
  • E
    Ep
     

    Home

    Biotech

    Cannabis

    Basic Materials

    Consumer Goods

    Tech

    Tips, Tricks & Facts



    Home  Biotech Stock News

    Biotech Stock News

    China Pharma Holdings (CPHI) Stock: Here’s Why It’s Flying!

    By

     Joshua Rodriguez

     -

    February 3, 2020

    0



    China Pharma Holdings, Inc. (NYSEAMERICAN: CPHI) is rocketing this morning, trading on gains of more than 50% early on. If you go digging for news, you’re not going to find any, but there is a good reason for the run. It seems as though the coronavirus has triggered a short squeeze. Here’s what’s going on.
    Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

    Why CPHI Stock Is Soaring

    After seeing that no press releases or SEC filings came out of China Pharma Holdings this morning, I took to social media to see if I could find the catalyst that started the short squeeze. What I found is what I believe to be a clear reason for the run.
    All over StockTwits and other investing-related social media platforms, I’m seeing posts surrounding the strategic positioning of the company in the midst of a deadly outbreak. Ultimately, the new virus known as coronavirus is spreading through China and has found its way to different areas around the world.
    While there are no approved products that are designed to treat coronavirus, the virus is an upper respiratory viral infection. This is where the strategic positioning of CPHI comes in.

    The company has several drugs on the Chinese market that are designed to treat the same types of symptoms that patients dealing with the coronavirus are experiencing. As such, the company’s already approved treatments may lead to the company being able to treat the condition.
    Moreover, CPHI currently owns the only bio manufacturing facility near the epicenter of the outbreak in China. So, not only does the company have drugs that may treat coronavirus, it has the facility and ability to make the treatments and get them to the targeted patient population very quickly.
    As investors start to realize the strategic advantage that the company has when it comes to the treatment of the coronavirus, we’re starting to see strong upward movement.
    In fact, before today, CPHI was a pretty heavily shorted stock. Considering the upward movement, those with short positions are losing money quickly. This generally leads to short sellers racing to buy shares in an attempt to cover their positions and cut the bleeding. All in all, this is what a short squeeze is made of.

    What’s Next?

    Really, there’s no telling what’s in store for China Pharma Holdings. There’s no doubt that we’re likely to see some profit taking when investors feel the time is right, but after that, this may be a huge opportunity.
    After all, if CPHI does indeed announce that it is working to treat the coronavirus, given its strategic advantages, the stock could soar as the treatment could quickly become a blockbuster. At the end of the day, only time will tell what happens next, but the stock seems like a pretty strong bet!
    Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

    Don’t Miss The Next Big Story!

    Join our free mailing list below to receive real-time news alerts!

    Subscribe Today!

    * indicates required

    Email Address *

    First Name

    TAGS

    Biotech Stock News

    CPHI

    Penny Stocks

    Previous articleInsmed (INSM) Stock Rockets On Trial Results

    Next articleVaxart (VXRT) Stock Continues Skyward On Coronavirus Program



    Joshua Rodriguez

    Hi, Im' Joshua Rodriguez. I'm the founder of Alpha Stock News and CNA Finance. I'm also one of the brains behind iWatch Markets and am often published on websites like Benzinga, US News & World Report, Yahoo! Finance, and several others. To get in touch, contact me through my Contact Page.

    RELATED ARTICLESMORE FROM AUTHOR



    Vaxart (VXRT) Stock Continues Skyward On Coronavirus Program



    Insmed (INSM) Stock Rockets On Trial Results



    Chesapeake Energy (CHK) Stock Heads Up On Production News

    LEAVE A REPLY

    Save my name, email, and website in this browser for the next time I comment.
     Notify me of follow-up comments by email.
     Notify me of new posts by email.

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Get FREE Actionable Updates!



    Latest News



    Vaxart (VXRT) Stock Continues Skyward On Coronavirus Program

    Joshua Rodriguez - February 3, 2020

    0

    Vaxart Inc (NASDAQ: VXRT) is having yet another strong day in the market today, following up on the gains that we saw from the...



    China Pharma Holdings (CPHI) Stock: Here’s Why It’s Flying!

    February 3, 2020



    Insmed (INSM) Stock Rockets On Trial Results

    February 3, 2020

    Alpha Stock News is not an investment advisor or broker/dealer. The articles published on this website are designed for information and entertainment purposes only. Before making any investment decisions, it is important to do your due diligence and consider speaking with an investing professional.

    © Alpha Stock News 2019
  • T
    The Daddy
    Being bought by insiders...spikes of 1-3 million in trades...big % of a small company bought up....Will be a soldier for the roll out of 1 Billion vaccine doses this year...up from 500 million according to the government mouthpiece newspaper. In the same breath, said newspaper described vaccine roll out in terms of :"war" to keep competitive with other countries. In war, you use all your soldiers. This is a moonshot.
    Bullish
  • k
    kai
    Very likely the company has returned back to profitable, with the additional revenues from selling the sanitizers.
    Bullish
  • S
    SS
    short covering will push the price much much higher. No shares available for sale. That is why big gap between bid and ask.
    Bullish
Advertisement
Advertisement